Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery (ERAS) Protocol in Subjects Undergoing Bowel Resection
Latest Information Update: 27 May 2024
At a glance
- Drugs TU 100 (Primary)
- Indications Postoperative ileus
- Focus Therapeutic Use
- Sponsors Tsumura
- 22 May 2024 Planned End Date changed from 1 Mar 2024 to 1 May 2024.
- 22 May 2024 Planned primary completion date changed from 1 Feb 2024 to 1 May 2024.
- 22 May 2024 Status changed from recruiting to active, no longer recruiting.